All Pharma News
price-trendAsk Us
Pulmocide exits OPERA with evidence of antifungal efficacy

Pulmocide exits OPERA with evidence of antifungal efficacy
Nick Paul Taylor FIERCE BIOTECH
15 Apr 2024
Share Share
Pulmocide OPERA-S Inhaled Opelconazole Phase 2 Positive Results

Pulmocide OPERA-S Inhaled Opelconazole Phase 2 Positive Results
GLOBENEWSWIRE
15 Apr 2024
Share Share
Pulmocide Announces Data Confirming Low Potential for Inhaled Opelconazole

Pulmocide Announces Data Confirming Low Potential for Inhaled Opelconazole
GLOBENEWSWIRE
16 Oct 2023
Share Share
Pulmocide Announces Expansion of Management Team

Pulmocide Announces Expansion of Management Team
GLOBENEWSWIRE
08 Jun 2023
Share Share
Pulmocide Raises $52 Mto Fund Additional Late-Stage Devp of Opelconazole

Pulmocide Raises $52 Mto Fund Additional Late-Stage Devp of Opelconazole
GLOBENEWSWIRE
06 Dec 2022
Share Share
Pulmocide’s lead drug candidate opelconazole (PC945) granted Orphan Drug

Pulmocide’s lead drug candidate opelconazole (PC945) granted Orphan Drug
GLOBENEWSWIRE
14 Sep 2021
Share Share